Skip to main content

Table 1 Baseline characteristics of the patients with HIV (HIV-VL) at the time of VL diagnosis

From: Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?

Sex, age (years)

HIV risk factora

Origin

Time between HIV and VL diagnoses

HCV co-infection

CD4

Viral loadb

HAART

Male, 48

PDU

Spain

27 years

HCV

99

348,063

No

Male, 46

PDU

Spain

20 years

HCV

4

563,499

No

Male, 34

Hetero

Peru

3 years

No

29

288,439

No

Female, 45

Hetero

Eq. Guinea

4 years

No

305

< 20

TDF/FTC/EFV

Male, 48

PDU

Spain

16 years

HCV

46

660,099

No

Male, 37

Hetero

Nigeria

3 months

No

322

21,511

No

Female, 21

Vertical

Eq. Guinea

21 years

No

16

60,600

No

Male, 32

Hetero

Romania

20 days

No

59

143,400

No

Male, 36

Hetero

Nigeria

6 days

No

4

1,169,645

No

Male, 39

MSM

Poland

5 months

No

48

149,661

No

Male, 33

MSM

Moldova

2 days

No

40

1,610,000

No

  1. aHow the patients became infected by HIV
  2. bNumber of RNA viral copies/ml at the moment of VL diagnosis
  3. Abbreviations: PDU, parenteral drug user; MSM, men who have sex with men; Hetero, heterosexual; CD4, number of CD4 cells/mm3 at the moment of VL diagnosis; HAART, highly active antiretroviral therapy; HCV, hepatitis C virus; TDF/FTC/EFV, tenofovir/emtricitabine/efavirenz